As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

MAIA Biotechnology, Inc.’s MAIA share price has dipped by 6.09%, which has investors questioning if this is right time to buy ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -8.30%), Recursion Pharmaceuticals ( RXRX -3.98%), and CRISPR Therapeutics ( CRSP -1.49%), plunged in March, with the stocks down 35.3%, ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Radiopharma biotech Cellectar Biosciences is seeking strategic alternatives, opening the door to further opportunities after ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector ...

The preclinical results were highlighted at the AACR Annual Meeting in Chicago, Illinois, on April 28, 2025, drawing ...

May has just begun, and it's time to turn our attention to the FDA decisions on deck for the coming weeks.So far this year, the U.S. regulatory agency has approved only ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...